Detalhe da pesquisa
1.
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis.
Ann Hematol
; 101(8): 1719-1726, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732976
2.
Haematological patients' perception of home transfusions: Effect of the COVID-19 pandemic.
Vox Sang
; 117(10): 1195-1201, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102110
3.
BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies.
Am J Hematol
; 96(10): 1195-1203, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34185336
4.
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice.
Am J Hematol
; 96(7): 790-795, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836555
5.
Safety and efficacy of blinatumomab: a real world data.
Ann Hematol
; 99(4): 835-838, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076826
6.
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.
Blood
; 129(13): 1791-1801, 2017 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126925
7.
Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control study.
Ann Hematol
; 98(12): 2711-2717, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31512015
8.
[CURRENT CRITERIA FOR THE DIAGNOSIS OF MYELOPROLIFERATIVE NEOPLASMS - WHAT IS IMPORTANT TO KNOW?]
Harefuah
; 158(11): 737-741, 2019 Nov.
Artigo
em Hebraico
| MEDLINE | ID: mdl-31721518
9.
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1.
Br J Haematol
; 176(6): 929-938, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28107546
10.
Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.
Am J Hematol
; 92(10): 1011-1019, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28631269
11.
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
Acta Haematol
; 135(3): 156-61, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26588173
12.
Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation.
Ann Hematol
; 94(3): 375-8, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25307457
13.
Outcome differences in patients with precursor B cell acute lymphocytic leukemia over time: a retrospective analysis.
Isr Med Assoc J
; 16(4): 224-8, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24834758
14.
Digoxin-associated decrease in parathyroid hormone (PTH) concentrations in patients with atrial fibrillation.
Eur J Clin Invest
; 43(2): 152-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23240707
15.
Timing of BNT162b2 vaccine prior to COVID-19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study.
Cancer Med
; 12(21): 20503-20510, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877352
16.
Ruxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still's Disease.
Eur J Rheumatol
; 9(4): 217-220, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943464
17.
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort Study.
Transplant Cell Ther
; 27(9): 788-794, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34214738
18.
Venetoclax is safe and efficacious in relapsed/refractory AML.
Leuk Lymphoma
; 61(9): 2221-2225, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32420775
19.
The serotonin syndrome: initial misdiagnosis.
Isr Med Assoc J
; 11(6): 367-70, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19697589
20.
Prevalence of Paroxysmal Nocturnal Hemoglobinuria Clones in Myeloproliferative Neoplasm Patients: A Cross-Sectional Study.
Clin Lymphoma Myeloma Leuk
; 19(12): 812-814, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601527